Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Stock option (right to buy) | 118K | Dec 29, 2023 | Direct | ||
Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock, $0.0001 par value | 84.6K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SNOA | Sonoma Pharmaceuticals, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Chief Financial Officer |
SNOA | Sonoma Pharmaceuticals, Inc. | Dec 29, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Interim CFO |
SNOA | Sonoma Pharmaceuticals, Inc. | Apr 7, 2023 | 0 | $0 | 3 | Apr 13, 2023 | Interim CFO |
SNOA | Sonoma Pharmaceuticals, Inc. | Jan 14, 2022 | 1 | $0 | 4 | Jan 14, 2022 | Chief Financial Officer |